Hepatoblastoma screening: Difference between revisions
Jump to navigation
Jump to search
Mahshid |
Aditya Ganti (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{NM}} | {{CMG}}; {{AE}} {{NM}} | ||
==Overview== | ==Overview== | ||
According to the American Association for the Study of Liver Diseases and United States Preventive Services Task Force, there is insufficient evidence to recommend routine screening for hepatoblastoma.<ref name=USPSTF>Hepatoblastoma. USPSTF. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=hepatoblastoma Accessed on November 3, 2015</ref><ref name=AASLD>Hepatoblastoma. AASLD. https://www.aasld.org/search/node/hepatoblastoma%20screening Accessed on November 3, 2015</ref> | According to the American Association for the Study of Liver Diseases and United States Preventive Services Task Force, there is insufficient evidence to recommend routine screening for hepatoblastoma.<ref name="USPSTF">Hepatoblastoma. USPSTF. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=hepatoblastoma Accessed on November 3, 2015</ref><ref name="AASLD">Hepatoblastoma. AASLD. https://www.aasld.org/search/node/hepatoblastoma%20screening Accessed on November 3, 2015</ref> | ||
==Screening== | ==Screening== | ||
According to the American Association for the Study of Liver Diseases and United States Preventive Services Task Force, there is insufficient evidence to recommend routine screening for hepatoblastoma.<ref name=USPSTF>Hepatoblastoma. USPSTF. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=hepatoblastoma Accessed on November 3, 2015</ref><ref name=AASLD>Hepatoblastoma. AASLD. https://www.aasld.org/search/node/hepatoblastoma%20screening Accessed on November 3, 2015</ref> | According to the American Association for the Study of Liver Diseases and United States Preventive Services Task Force, there is insufficient evidence to recommend routine screening for hepatoblastoma.<ref name="USPSTF">Hepatoblastoma. USPSTF. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=hepatoblastoma Accessed on November 3, 2015</ref><ref name="AASLD">Hepatoblastoma. AASLD. https://www.aasld.org/search/node/hepatoblastoma%20screening Accessed on November 3, 2015</ref> | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 19:46, 13 March 2019
|
Hepatoblastoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hepatoblastoma screening On the Web |
|
American Roentgen Ray Society Images of Hepatoblastoma screening |
|
Risk calculators and risk factors for Hepatoblastoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
According to the American Association for the Study of Liver Diseases and United States Preventive Services Task Force, there is insufficient evidence to recommend routine screening for hepatoblastoma.[1][2]
Screening
According to the American Association for the Study of Liver Diseases and United States Preventive Services Task Force, there is insufficient evidence to recommend routine screening for hepatoblastoma.[1][2]
References
- ↑ 1.0 1.1 Hepatoblastoma. USPSTF. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=hepatoblastoma Accessed on November 3, 2015
- ↑ 2.0 2.1 Hepatoblastoma. AASLD. https://www.aasld.org/search/node/hepatoblastoma%20screening Accessed on November 3, 2015